
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            The story of elimination of visceral leishmaniasis (kala-azar) in India—Challenges towards sustainment - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="15254B878AF3A343054B870041FEA6A8.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="plosntd">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364345/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="PLOS Neglected Tropical Diseases">
<meta name="citation_title" content="The story of elimination of visceral leishmaniasis (kala-azar) in India—Challenges towards sustainment">
<meta name="citation_author" content="Shyam Sundar">
<meta name="citation_author_institution" content="Department of General Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India">
<meta name="citation_publication_date" content="2025 Aug 19">
<meta name="citation_volume" content="19">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="e0013321">
<meta name="citation_doi" content="10.1371/journal.pntd.0013321">
<meta name="citation_pmid" content="40828749">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364345/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364345/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364345/pdf/pntd.0013321.pdf">
<meta name="description" content="The earliest record of visceral leishmaniasis (kala-azar, KA, VL) dates back two centuries from Jessore (now in Bangladesh), with 0.75 million deaths in 3 years. In the 1950s, there was extensive insecticide dichlorodiphenyltrichloroethane (DDT) ...">
<meta name="og:title" content="The story of elimination of visceral leishmaniasis (kala-azar) in India—Challenges towards sustainment">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The earliest record of visceral leishmaniasis (kala-azar, KA, VL) dates back two centuries from Jessore (now in Bangladesh), with 0.75 million deaths in 3 years. In the 1950s, there was extensive insecticide dichlorodiphenyltrichloroethane (DDT) ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364345/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12364345">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1371/journal.pntd.0013321"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/pntd.0013321.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12364345%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12364345/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12364345/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364345/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-plosntd.png" alt="PLOS Neglected Tropical Diseases logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to PLOS Neglected Tropical Diseases" title="Link to PLOS Neglected Tropical Diseases" shape="default" href="https://doi.org/10.1371/journal.pntd.0013321" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">PLoS Negl Trop Dis</button></div>. 2025 Aug 19;19(8):e0013321. doi: <a href="https://doi.org/10.1371/journal.pntd.0013321" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pntd.0013321</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22PLoS%20Negl%20Trop%20Dis%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22PLoS%20Negl%20Trop%20Dis%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22PLoS%20Negl%20Trop%20Dis%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22PLoS%20Negl%20Trop%20Dis%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>The story of elimination of visceral leishmaniasis (kala-azar) in India—Challenges towards sustainment</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sundar%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Shyam Sundar</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Shyam Sundar</span></h3>
<div class="p">
<sup>1</sup>Department of General Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sundar%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shyam Sundar</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>
</div>
<div class="cg p">Editor: <span class="name western">Mitali Chatterjee</span><sup>2</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff001">
<sup>1</sup>Department of General Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India</div>
<div id="edit1">
<sup>2</sup>Institute of Postgraduate Medical Education and Research, INDIA</div>
<div class="author-notes p">
<div class="fn" id="coi001"><p>The author has declared that no competing interests exist.</p></div>
<div class="fn" id="cor001">
<sup>✉</sup><p class="display-inline">* E-mail: <span>drshyamsundar@hotmail.com</span></p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Mitali Chatterjee</span></strong>: <span class="role">Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Collection date 2025 Aug.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 Shyam Sundar</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12364345  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40828749/" class="usa-link">40828749</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>The earliest record of visceral leishmaniasis (kala-azar, KA, VL) dates back two centuries from Jessore (now in Bangladesh), with 0.75 million deaths in 3 years. In the 1950s, there was extensive insecticide dichlorodiphenyltrichloroethane (DDT) spray under the aegis of the National Malaria Eradication Program. As a corollary benefit, there was a sharp decline in the incidence of VL due to the reduced prevalence of the vector to extremely low levels, resulting in substantial decreases in the number of KA cases. In the early 1970s, a surge in the number of cases was noted, and since then, it has taken the shape of the current epidemic. In 1990–91, the National Kala-azar Control Program was launched in India, though without much impact due to the diminishing efficacy of treatment with pentavalent antimonial. This was followed by the introduction of highly effective amphotericin B deoxycholate. In 2005, the Kala-azar Elimination Program (KAEP) was launched jointly by India, Bangladesh, and Nepal, with treatment initially with oral miltefosine, succeeded later by single-dose liposomal amphotericin B (AmBisome), and in 2023, India achieved the goal of kala-azar elimination, defined as an incidence below 1 per 10,000 at sub-district (block) level. Patients with post kala-azar dermal leishmaniasis, HIV-VL coinfection, and undiagnosed/untreated VL patients are the human sources for the vector. They may herald an outbreak resulting in the commencement of a new epidemic. Active case detection, early diagnosis, and prompt, complete treatment are required to prevent fresh transmission. Periodic updates of health personnel, community awareness, and continued availability of the theragnostics are important steps for early detection and containment of an outbreak.</p></section><section class="abstract" id="abstract2"><h2>Author summary</h2>
<p>After extensive DDT spray in the 1950s for the National Malaria Eradication Programme, the incidence of kala-azar (visceral leishmaniasis, VL, KA) declined remarkably in India. However, in the early 1970s, a resurgence of VL was noticed, which took enormous proportions, and an estimated several hundred thousand cases of VL occurred between the 1970s and 2000s. Unfortunately, the efficacy of the only available anti-kala-azar drug, sodium stibogluconate, declined sharply, and the cure rate plummeted to 35%. Thus, a huge proportion of kala-azar patients were left without any effective treatment. It was a desperate state for a physician like me; amphotericin B deoxycholate came to the rescue, but only for a small proportion of patients because of the logistics involved (unaffordable cost, ~ 5 weeks of hospitalization, high incidence of adverse reactions, etc.). We came across miltefosine, the first oral anti-VL drug, and with a 10-minute VL rapid diagnostic test, the Kala-azar Elimination Programme came to the rescue of the sufferers of this dreaded disease. After a single-dose treatment with liposomal amphotericin B (AmBisome, Gilead Sciences, Foster City, USA) was successfully implemented in this programme, a steep decline in the prevalence of VL occurred. In the year 2023, the goal of the Elimination Programme was achieved in all 633 VL endemic blocks of India. However, being a source of parasites, patients with post kala-azar dermal leishmaniasis, HIV-VL coinfection, and undiagnosed VL, pose a threat for new outbreaks, and a constant vigil is needed for early detection and containment of these.</p></section><section id="sec001"><h2 class="pmc_sec_title">Background</h2>
<p>Visceral leishmaniasis (VL) is a life-threatening, vector-borne disease that is invariably fatal if untreated. Globally, an estimated incidence of 30000 [<a href="#pntd.0013321.ref001" class="usa-link" aria-describedby="pntd.0013321.ref001">1</a>] new cases are reported annually across 99 countries. In 2023, approximately 83% of global VL cases were reported from seven countries: Brazil, Ethiopia, India, Kenya, Somalia, South Sudan, and Sudan [<a href="#pntd.0013321.ref002" class="usa-link" aria-describedby="pntd.0013321.ref002">2</a>]. In the Indian subcontinent (ISC), India accounts for the majority of VL cases, and most of the cases are from the state of Bihar. In ISC, VL is caused by <em>Leishmania donovani</em> transmitted anthroponotic (human to human) by the sandfly vector <em>Phlebotomus argentipes.</em> Although there are reports of dogs transmitting <em>L. donovani</em> to sandflies in India, its role in human transmission is yet to be established [<a href="#pntd.0013321.ref003" class="usa-link" aria-describedby="pntd.0013321.ref003">3</a>].</p>
<p>VL has been present in India for centuries. The earliest documentation of VL in India can be traced back to 1824–1825, when an outbreak of fever in Jessore (now in Bangladesh), known as jwarvikar (“fever disease”), caused approximately 750,000 deaths over 3 years [<a href="#pntd.0013321.ref004" class="usa-link" aria-describedby="pntd.0013321.ref004">4</a>]. VL was almost eliminated in India in the 1950s following extensive insecticide spraying under the National Malaria Eradication Program. However, in the year 1974, a resurgence was reported, initially in a small region of North Bihar affecting four districts (Vaishali, Muzaffarpur, Samastipur, and Sitamarhi). After that, VL became endemic across the entire state of Bihar, some parts of the state of Jharkhand, several districts in the state of West Bengal, and the eastern districts of Uttar Pradesh [<a href="#pntd.0013321.ref005" class="usa-link" aria-describedby="pntd.0013321.ref005">5</a>,<a href="#pntd.0013321.ref006" class="usa-link" aria-describedby="pntd.0013321.ref006">6</a>]. The VL incidence increased, and in the year 1977, the recorded incidence was 18,743, and two peaks in the annual incidences were noted with 42,033, and 77,102 in the years 1978 and 1992, respectively (<a href="#pntd.0013321.g001" class="usa-link">Fig 1</a>). These were not the real numbers and could be 4.2–8 times more as there was significant underreporting [<a href="#pntd.0013321.ref007" class="usa-link" aria-describedby="pntd.0013321.ref007">7</a>,<a href="#pntd.0013321.ref008" class="usa-link" aria-describedby="pntd.0013321.ref008">8</a>]. Thus, the actual incidence of VL might have been in several hundreds of thousands during these years.</p>
<figure class="fig xbox font-sm" id="pntd.0013321.g001"><h3 class="obj_head">Fig 1. Annual incidence of visceral leishmaniasis in India from 1977 to 2023 with the treatments used (Source of data: National Center of Vector Borne Diseases Control, Government of India).</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12364345_pntd.0013321.g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce4b/12364345/0a9769d9807e/pntd.0013321.g001.jpg" loading="lazy" height="353" width="750" alt="Fig 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/pntd.0013321.g001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>There were several issues in managing VL in this era; the diagnosis was dependent on the demonstration of parasites in tissue smears from the bone marrow or spleen. However, it was expensive with limited availability, often delaying the diagnosis and subsequently the treatment. Treatment was solely dependent on 30-day parenteral treatment with pentavalent antimony, sodium stibogluconate (Sb<sup>V</sup>). There was widespread resistance to Sb<sup>V</sup>, and hence, a vast majority of VL patients with active disease remained roaming in the community with a rich source of parasites, continuously propagating the transmission of the disease.</p>
<p>The Government of India launched a centrally sponsored Kala-azar Control Programme in 1990–91. The programme was intensified during the year 1991, resulting in a reduction of morbidity and mortality to 22,625 cases and 277 deaths in 1995 in comparison to a peak incidence of 77,102 cases and 1,419 deaths reported during 1992 [<a href="#pntd.0013321.ref009" class="usa-link" aria-describedby="pntd.0013321.ref009">9</a>]. However, unfortunately, during these years (the 1990s to early 2000s), the efficacy of the pentavalent antimonial (sodium stibogluconate; Sb<sup>V</sup>) plummeted to 35–36% [<a href="#pntd.0013321.ref010" class="usa-link" aria-describedby="pntd.0013321.ref010">10</a>,<a href="#pntd.0013321.ref011" class="usa-link" aria-describedby="pntd.0013321.ref011">11</a>].</p>
<p>The only alternative during these years, was amphotericin B deoxycholate (AmB), though highly effective (cure rate &gt;98%), the safety profile of AmB is not good, and 5–6 weeks of hospitalization is necessary for 15–20 intravenous infusions (daily or alternate days) with continuous laboratory monitoring [<a href="#pntd.0013321.ref012" class="usa-link" aria-describedby="pntd.0013321.ref012">12</a>,<a href="#pntd.0013321.ref013" class="usa-link" aria-describedby="pntd.0013321.ref013">13</a>]. With these handicaps, there was a massive shortage of hospital beds for such a large number of patients. Initially, AmB was primarily reserved for patients with Sb<sup>V</sup> treatment failure. In August 2000, the National Expert Committee on Kala-azar recommended the use of AmB as the primary treatment for VL endemic areas where the rate of Sb<sup>V</sup> treatment failure was greater than 10%. However, because of the reasons stated above, the use of AmB as a first-line treatment did not succeed. Dependence on ineffective Sb<sup>V</sup> continued.</p>
<p>Meanwhile, oral miltefosine (MF) became available as an effective antileishmanial drug and was approved for the treatment of VL in India in 2002 [<a href="#pntd.0013321.ref012" class="usa-link" aria-describedby="pntd.0013321.ref012">12</a>,<a href="#pntd.0013321.ref014" class="usa-link" aria-describedby="pntd.0013321.ref014">14</a>]. ‘At that time the rK39 rapid immunochromatographic test became available, allowing a presumptive diagnosis based on the combination of specific symptoms and presence of antibodies in a capillary blood sample’. [<a href="#pntd.0013321.ref015" class="usa-link" aria-describedby="pntd.0013321.ref015">15</a>], complemented by the ease of administration of oral MF treatment, both of these new diagnostic and treatment tools were easily deployable in the most remote health facilities in India as well as in Nepal and Bangladesh. Thus, the stage was set for an aggressive KA control program, in 2005, a joint Kala-azar Elimination Programme (KAEP) was launched by the Governments of India, Nepal, and Bangladesh to reduce the annual incidence of VL to less than 1 case per 10,000 population at the sub-district level by 2015 [<a href="#pntd.0013321.ref016" class="usa-link" aria-describedby="pntd.0013321.ref016">16</a>].</p>
<p>The key strategies adopted for the National KAEP were as follows [<a href="#pntd.0013321.ref017" class="usa-link" aria-describedby="pntd.0013321.ref017">17</a>]:</p>
<ol class="list" style="list-style-type:decimal">
<li><p>Early diagnosis and complete case management</p></li>
<li><p>Integrated vector management (IVM) and vector surveillance</p></li>
<li><p>Supervision, monitoring, surveillance, and evaluation</p></li>
<li><p>Strengthening capacity of human resource in health</p></li>
<li><p>Advocacy, communication, and social mobilization for behavioral impact and inter-sectoral convergence</p></li>
<li><p>Programme management</p></li>
</ol>
<section id="sec002"><h3 class="pmc_sec_title">Progress made in VL elimination initiatives</h3>
<p>In 2005, when the VL elimination initiatives started, an estimated 165.4 million people in India were at risk of leishmania infection, and 34,803 active VL cases were reported from 633 public health center (PHC) blocks across four states that were endemic (<a href="#pntd.0013321.g001" class="usa-link">Figs 1</a> and <a href="#pntd.0013321.g002" class="usa-link">2</a>). This included 33 districts and 458 blocks of Bihar; 4 districts and 33 blocks of Jharkhand; 11 districts and 120 blocks of West Bengal; and 6 districts and 22 blocks of Uttar Pradesh. The reported VL case load in the region decreased significantly, from over 34,803 cases in 2005 to fewer than 8,243 cases in 2015, and further declined to 524 cases in 2023 (<a href="#pntd.0013321.g001" class="usa-link">Fig 1</a>). Similarly, the number of endemic blocks attaining the elimination target of less than 1 in 10,000 decreased from 633 in 2005 to 136 in 2015, 8 in 2021, and ultimately reached 0 by 2023 (<a href="#pntd.0013321.g002" class="usa-link">Fig 2</a>). The last block that achieved the elimination target was in Pakur district, Jharkhand. Through the VL elimination initiatives, the number of VL cases in India significantly declined, and by 2023, the South East Asia Region of WHO (India, Bangladesh, and Nepal) reported only 6% of cases reported from the world [<a href="#pntd.0013321.ref018" class="usa-link" aria-describedby="pntd.0013321.ref018">18</a>,<a href="#pntd.0013321.ref019" class="usa-link" aria-describedby="pntd.0013321.ref019">19</a>].</p>
<figure class="fig xbox font-sm" id="pntd.0013321.g002"><h4 class="obj_head">Fig 2. Progress towards achievement of the kala-azar elimination from 2011 to 2023 (Source of data: National Center of Vector Borne Diseases Control, Government of India).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12364345_pntd.0013321.g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce4b/12364345/c9b139b8754c/pntd.0013321.g002.jpg" loading="lazy" height="341" width="750" alt="Fig 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/pntd.0013321.g002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>In 2023, the WHO certified Bangladesh as the first country to be validated for VL elimination as a public health problem. In December 2023, India also achieved the elimination threshold in all implementation units (<a href="#pntd.0013321.g002" class="usa-link">Fig 2</a>) and transitioned into the consolidation phase of sustaining elimination for a minimum of three consecutive years before submitting a dossier to the WHO for validation. In 2023, the rates in two implementation units in Nepal were above the elimination threshold. Due to the success of the elimination initiative in the WHO-SEAR, which now has 6% of the worldwide burden and the fewest cases since the launch of the elimination initiative in 2005 [<a href="#pntd.0013321.ref020" class="usa-link" aria-describedby="pntd.0013321.ref020">20</a>].</p></section><section id="sec003"><h3 class="pmc_sec_title">Challenges and threats to sustainment of VL elimination</h3>
<p>As India has achieved the goal of elimination, there are challenges to prevent new outbreaks, as there are lurking dangers of the restart of the epidemic due to persistent parasites, in the form of human reservoirs, circulating in the community. Primarily A—post kala-azar dermal leishmaniasis and B—HIV-VL coinfection.</p>
<p>The asymptomatic infected individuals, though speculated to play a part in the transmission, however, in a xenodiagnosis study involving 184 subjects with high antileishmanial antibody titers, none of the sandflies could be infected by any individual from this cohort [<a href="#pntd.0013321.ref021" class="usa-link" aria-describedby="pntd.0013321.ref021">21</a>]. Thus, it was concluded that these individuals may play only an insignificant role in the transmission of VL. Active case detection with early initiation of treatment could minimize the contribution of patients with unrecognized illness in the disease transmission.</p>
<p>There have been reports of VL from hilly states of India like Himachal Pradesh and Uttarakhand. From Nepal also, outbreaks of VL have been reported from highlands, though earlier, only a few districts from the Southeast region (low land area) were endemic for VL. These changes in endemicity do hint at the effects of climate change, with vectors being able to migrate to higher altitudes.</p></section><section id="sec004"><h3 class="pmc_sec_title">Early diagnosis and treatment</h3>
<p>There is clear evidence that VL tends to cluster within household members, close contacts, and neighborhood contacts. This phenomenon suggests that VL patients may play a significant role in transmission. It has been proven through xenodiagnosis studies that, indeed, these patients do transmit the infection to the vectors quite proficiently. In a study from India, 60 (78%) of 77 patients with VL transmitted parasite infection to the sandflies [<a href="#pntd.0013321.ref021" class="usa-link" aria-describedby="pntd.0013321.ref021">21</a>]. In another study from Bangladesh, 66.7% of VL patients infected the sandflies. [<a href="#pntd.0013321.ref022" class="usa-link" aria-describedby="pntd.0013321.ref022">22</a>]. These findings underscore the importance of early diagnosis and effective treatment of VL. With the introduction of rapid diagnosis of VL by rK39 immunochromatographic strip test, early detection of VL has become possible, though the rK39 rapid diagnostic test is highly specific for the anti-K39 antibody detection [<a href="#pntd.0013321.ref015" class="usa-link" aria-describedby="pntd.0013321.ref015">15</a>], with significantly decreased incidence of VL, a seropositive subject should be looked for clinical/laboratory features of VLIf needed, parasitological or PCR confirmation of presumptive diagnosis by rapid test can also play a role.</p>
<p>This could be an important step in restricting the transmission. Similarly, and more essentially, to break the transmission chain effectively and early, another important step will be to start effective treatment immediately, with an appropriate follow-up, till a definitive cure is achieved. Single-dose liposomal amphotericin B (LAmB) treatment has been a great success in the treatment of VL [<a href="#pntd.0013321.ref023" class="usa-link" aria-describedby="pntd.0013321.ref023">23</a>], and its deployment in the KAEP has been the most important factor in the achievement of the elimination goal in India and Bangladesh. Being with an impeccable safety profile, its use in the treatment of VL is possible even at the most peripheral health set-up in the endemic areas of ISC. Its prompt use in the treatment of VL will have a pivotal role in successfully restricting the transmission of this disease.</p>
<p>Although LAmB, used in the KAEP, is available as a free donation from the manufacturer Gilead Sciences, Foster City, US, it is unaffordable and expensive in the open market (60 US$ for a 50 mg vial) in India. The good news is that now indigenous liposomal Amphotericin B formulations are available at much lower price (12–14 US$/50 mg), though equivalence studies need to be done to validate the safety and efficacy profile of these new formulations. Unfortunately, with a steep decline in the number of VL patients, it will be impossible to conduct such studies.</p></section><section id="sec005"><h3 class="pmc_sec_title">Post kala-azar dermal leishmaniasis (PKDL)</h3>
<p>In India, within 1–3 years or longer post-treatment for VL, a small percentage (5–15%) of individuals develop skin eruptions such as nodules or papules, a condition termed PKDL [<a href="#pntd.0013321.ref024" class="usa-link" aria-describedby="pntd.0013321.ref024">24</a>]. The primary importance of PKDL derives from its role as an infection reservoir [<a href="#pntd.0013321.ref021" class="usa-link" aria-describedby="pntd.0013321.ref021">21</a>]. PKDL patients are not systemically ill and may remain untreated for years. Treatment requires inordinately long courses of sodium stibogluconate (SSG) [<a href="#pntd.0013321.ref025" class="usa-link" aria-describedby="pntd.0013321.ref025">25</a>] or AmB [<a href="#pntd.0013321.ref026" class="usa-link" aria-describedby="pntd.0013321.ref026">26</a>] and, more recently, of MF [<a href="#pntd.0013321.ref027" class="usa-link" aria-describedby="pntd.0013321.ref027">27</a>]. These patients are human reservoirs for the parasites and may initiate fresh outbreaks. There are reports of VL outbreaks attributed to patients of PKDL. Cases of persistent PKDL in West Bengal have been implicated as the origin of the resurgence of VL in that region [<a href="#pntd.0013321.ref028" class="usa-link" aria-describedby="pntd.0013321.ref028">28</a>,<a href="#pntd.0013321.ref029" class="usa-link" aria-describedby="pntd.0013321.ref029">29</a>]. A large number of patients with PKDL (<a href="#pntd.0013321.g003" class="usa-link">Fig 3</a>) can have the lesion for years without seeking treatment and, thus, could be infectious for a longer time than patients with active VL. If untreated, the disease persists as there is no self-cure, unlike Sudanese PKDL. Patients with nodular PKDL were more infectious to sandflies than patients with macular PKDL, both in the proportion of flies infected and in the number of parasites transmitted. Interestingly, during a xenodiagnosis study, sandflies fed on the normal skin of patients, with only macular PKDL, were able to pick up leishmania infection [<a href="#pntd.0013321.ref021" class="usa-link" aria-describedby="pntd.0013321.ref021">21</a>]. These findings underscore the important role that patients with PKDL play in the transmission of leishmanial infection, irrespective of the morphology of the lesions.</p>
<figure class="fig xbox font-sm" id="pntd.0013321.g003"><h4 class="obj_head">Fig 3. Post kala-azar dermal leishmaniasis (PKDL) situation in India during 2013–2023 (Source of data: National Center of Vector Borne Diseases Control, Government of India).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12364345_pntd.0013321.g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce4b/12364345/0064025f5030/pntd.0013321.g003.jpg" loading="lazy" height="343" width="750" alt="Fig 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/pntd.0013321.g003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>Except for the aesthetic concerns, there are no physical disabilities beyond cosmetic disfigurement. In a significant proportion of patients, these lesions are not of major concern. Thus, most patients are reluctant to undergo treatment. Sometimes, severe cosmetic disfigurement, with associated stigma, drives patients to seek treatment. ‘Unfortunately, treatment regimens for PKDL are far from satisfactory. Previously, inordinately prolonged and toxic treatments were recommended for its management. The standard recommendation with Sb<sup>V</sup> treatment of PKDL was intramuscular injections in doses of 20mg/kg daily for 120 days, and in case of inadequate response, the treatment could be extended up to a maximum of 200 days [<a href="#pntd.0013321.ref025" class="usa-link" aria-describedby="pntd.0013321.ref025">25</a>,<a href="#pntd.0013321.ref030" class="usa-link" aria-describedby="pntd.0013321.ref030">30</a>]. In case of Sb<sup>V</sup> failure, three to four 20-day courses of intravenous infusion of AmB (1mg/kg) is recommended with a treatment-free interval of 20 days [<a href="#pntd.0013321.ref026" class="usa-link" aria-describedby="pntd.0013321.ref026">26</a>]. In the WHO recommendations of the year 2010, a 12-week treatment of oral MF is recommended [<a href="#pntd.0013321.ref031" class="usa-link" aria-describedby="pntd.0013321.ref031">31</a>]. Each one of these PKDL treatment regimens, in addition to being protracted, is associated with unacceptable toxicities. Sb<sup>V</sup> can cause serious and occasionally fatal cardiotoxicities [<a href="#pntd.0013321.ref011" class="usa-link" aria-describedby="pntd.0013321.ref011">11</a>]. With AmB, high incidence of infusion reactions, frequent nephrotoxicity, hypokalemia, and cardiotoxicity are limiting factors. With prolonged MF treatment of PKDL patients, ocular toxicity (partially reversible) [<a href="#pntd.0013321.ref032" class="usa-link" aria-describedby="pntd.0013321.ref032">32</a>] is a serious concern; potential teratogenicity of MF rules out its use in pregnancy, and further, it necessitates contraceptive practices for the duration of the treatment and an additional 5 months. In a nutshell, currently, available PKDL treatment regimens are far too prolonged, toxic, expensive, and unacceptable; incomplete treatment and frequent dropouts limit successful therapy. However, a recent report of treatment of PKDL with liposomal amphotericin B (LAmB), at a total dose of 20 mg/kg in five divided doses administered over 2 weeks, led to a final cure of 83% of patients at a 24-month follow-up. This short-duration 2-week therapy is patient-friendly, which will be more acceptable to PKDL patients [<a href="#pntd.0013321.ref033" class="usa-link" aria-describedby="pntd.0013321.ref033">33</a>].</p>
<p>The unfortunate part about PKDL is that interest in this important entity has been much lower from academia, industry, and national control programmes of the ISC as well as the World Health Organization (WHO). However, since 2011, WHO has been strengthening the countries’ surveillance of PKDL, In the last decade (years 2014–2023), a total of 9,108 cases have been reported from India [<a href="#pntd.0013321.ref019" class="usa-link" aria-describedby="pntd.0013321.ref019">19</a>]. There is an urgent need to implement the recently described 2-week treatment [<a href="#pntd.0013321.ref033" class="usa-link" aria-describedby="pntd.0013321.ref033">33</a>] and further research to find an even shorter, safe, and affordable (preferably oral) regimen for the treatment of PKDL.</p></section><section id="sec006"><h3 class="pmc_sec_title">HIV-VL co-infection</h3>
<p>In India, the prevalence of HIV among VL patients has increased from 0.88% in 2000 to 2.18% in 2006 [<a href="#pntd.0013321.ref034" class="usa-link" aria-describedby="pntd.0013321.ref034">34</a>–<a href="#pntd.0013321.ref036" class="usa-link" aria-describedby="pntd.0013321.ref036">36</a>]. In 2022, WHO reported that up to 5–7% of patients with VL in India were identified with HIV co-infection, marking the highest rate in South Asia [<a href="#pntd.0013321.ref037" class="usa-link" aria-describedby="pntd.0013321.ref037">37</a>]. It has been shown that HIV-VL co-infected patients transmit the <em>L. donovani</em> infection very efficiently. These patients remain infectious for long periods, as they are unable to clear the infection completely and keep relapsing with signs and symptoms of VL. Due to their potentially high parasitic load and increased tendency to relapse, HIV-VL co-infected patients are capable of transmitting the disease very efficiently. HIV-VL coinfected patients are highly infectious to sandflies in the endemic areas in India [<a href="#pntd.0013321.ref038" class="usa-link" aria-describedby="pntd.0013321.ref038">38</a>] for extended periods. In a xenodiagnosis study, 93% (13/14) of the VL-HIV group successfully transmitted the leishmania infection to the sandflies and were three times more infectious than those who had VL without HIV. Thus, HIV-VL coinfected patients are a big threat to maintaining the status of elimination. It is important that these patients are searched actively and treated strenuously for both diseases. Fortunately, for both of these diseases, free treatment is available in India. Prevention of VL relapses is vital, and this can only be done by effective antiretroviral treatment with successful antileishmanial therapy. It is also recommended that prophylactic monthly AmB or liposomal amphotericin B therapy be administered till a CD4 + count of ≥350 is achieved [<a href="#pntd.0013321.ref039" class="usa-link" aria-describedby="pntd.0013321.ref039">39</a>].</p></section><section id="sec007"><h3 class="pmc_sec_title">Vector control and environmental measures</h3>
<p>The indoor resting behavior of sandfly (<em>P. argentipes</em>) makes them a suitable target for control by indoor residual spraying (IRS) with insecticides. As a result, control of malaria with DDT starting in 1950s immensely benefitted VL control in the ISC from 1953 to 1962, IRS undertaken by the Indian National Malaria Program using DDT for malaria control had immense beneficial side effect of controlling sandflies and significantly reducing the number of VL cases in the ISC [<a href="#pntd.0013321.ref040" class="usa-link" aria-describedby="pntd.0013321.ref040">40</a>,<a href="#pntd.0013321.ref041" class="usa-link" aria-describedby="pntd.0013321.ref041">41</a>]. This collateral benefit led to the adoption of IRS with DDT by the Indian VL elimination program as the main focus for <em>P. argentipes</em> control. After the resurgence of VL in the ISC and the launch of KAEP, DDT was used to eliminate the VL vector from the country [<a href="#pntd.0013321.ref042" class="usa-link" aria-describedby="pntd.0013321.ref042">42</a>]. Sandflies were known to be susceptible to DDT until the first report of resistance in <em>P. argentipes</em> in 1993 [<a href="#pntd.0013321.ref043" class="usa-link" aria-describedby="pntd.0013321.ref043">43</a>]. Given the paramount importance of IRS to the VL control effort, the National Vector Borne Disease Control Programme changed to an effective insecticide, the synthetic pyrethroid alpha-cypermethrin (5%) as an alternative in the second phase of IRS and altered the mode of application to hand compression pumps to improve the quality of IRS delivery. Continuous monitoring of the insecticide resistance should be in place for timely intervention and course correction in case the emergence of insecticide resistance is detected.</p>
<p>Sustained vector control is an important component to bring down/stop the transmission of VL. IRS should be continued with the same vigour and zeal as in the pre-elimination era. Insecticide selection should be judicious, with constant monitoring of their sensitivity. Implementing an IVM approach, which combines biological, chemical, and environmental control methods, can enhance the effectiveness of vector management efforts.</p>
<p>IRS activities are resource incentive; other methods of vector control are also vital. One of the most important steps is modifying the environment and abrogating the breeding sites. Financial assistance for the conversion of straw or mud dwellings into plastered brick houses for removing the cracks/crevices, the sites for sandfly breeding. Animal shelters should be modified to prevent the sites for vector breeding, etc. Ultimately, instead of blanket spray, focal spray around the areas of an outbreak could be a viable alternative.</p>
<p>As the elimination goal is achieved, the political and donor interests are bound to decline; however, strengthening the Primary Health Centers by integrating the resources set aside for management of various vector-borne diseases like VL, malaria, and filaria is likely to be the way forward. The close collaboration between India, Nepal, and Bangladesh, as existed in the pre-elimination era, should continue. WHO–South East Asia Regional Office (SEARO) must continue its important role through the Regional Technical Advisory Group (RTAG) in coordinating the efforts for elimination, which is very important.</p></section><section id="sec008"><h3 class="pmc_sec_title">Surveillance</h3>
<p>Active case detection for early recognition of VL and PKDL; and early diagnosis and treatment are of paramount importance in the recognition and containment of new outbreaks. Community education for the two leishmanial diseases should be continued for continued awareness. Periodic refresher workshops for healthcare providers are extremely important for continued updating of knowledge. Continued availability of appropriate diagnostic and treatment facilities for both VL and PKDL must be ensured during the post-elimination phase.</p></section><section id="sec009"><h3 class="pmc_sec_title">Role of various stakeholders in KAEP</h3>
<p>Although the KAEP was largely funded by the Government of India, partnerships with various global agencies played an important role in the success of the program. WHO headquarters and its SEARO formed an RTAG, which helped in policy making, and if needed, course corrections were advised periodically. Bill and Melinda Gates Foundation’s financial, technical, and research support has been important in the success of the KAEP in the ISC. Other agencies like the Foreign, Commonwealth and Development Office (FCDO), UK, the National Institute of Allergy and Infectious Diseases, and National Institute of Health, US, also supported the program, funding important research and program implementation.</p>
<p>Academia played a very important role in developing tools for elimination, early diagnosis with rK39 RDTs played a crucial part resulting in the quick identification and elimination of the VL, similarly clinical development of oral MF provided an important alternative to Ampho B/ Sb<sup>V</sup> treatment, these two innovations were vital which made the possibility of the very concept to KAEP in the ISC. Later in the program, single-dose LAmB (AmBisome) treatment, which was introduced in the program in the year 2014, played the most important role in achieving the goal of KAEP.</p>
<p>The National Center for Vector-Borne Disease Control (NCVBDC) played an important role in the implementation of national health strategies and allocated domestic funding. Strengthen disease surveillance, ensure early diagnosis, and provide free treatment. The state health machinery executed these tasks. Similarly, vector control implementation with the IRS, surveillance, and case management, with training of healthcare workers at various levels for early case detection and treatment, was guided by the central agency and executed by the state governments. NCVBDC has also been maintaining the national register of kala-azar, PKDL, and HIV-VL patients and has done an impeccable job since the onset of the VL epidemic in the early 1970s till date.</p>
<p>Non-governmental organizations like PATH (Program for Appropriate Technology in Health), DND<em>i</em> (Drugs for Neglected Diseases initiative), and CARE India (Cooperative for Assistance and Relief Everywhere) collaborated with the governmental machinery for the success of KAEP. PATH assisted in streamlining logistics and distribution of diagnostics and treatment drugs and training of health care personnel. CARE did community mobilization and developed the Kala-azar Management Information System (KAMIS) database, which was extremely helpful in reporting and monitoring the progress of KAEP in real time. NCVBDC, with the help of state machinery, is maintaining the KAMIS database now. DND<em>i</em> supported several clinical trials in kala-azar and PKDL.</p></section><section id="sec010"><h3 class="pmc_sec_title">Limitations</h3>
<p>Diagnosis has been based on antibody detection, which has several pitfalls. Antibodies, being persistent for several years after cure, do not offer a test of cure and are of no use in the diagnosis of relapses. There is a need for rapid antigen detection tests which will be devoid of the demerits enumerated above.</p>
<p>Single-dose LAmB treatment was key to the success of KAEP, but this is dependent on the donation program, which was the result of WHO negotiations with Gilead Sciences, and it continues till the end of 2025. It is important to assess the generic LAmB’s safety and efficacy in the treatment of VL, to ensure the ready availability of the drug for sporadic cases. Low numbers of patients is a severe handicap in the successful development of new drugs for clinical use. It remains crucial to develop new safe and effective oral antileishmanial drugs, obviating the need of infusions. A cold chain is needed for the transport and storage of LAmB, and this is a great challenge in the endemic areas of ISC, where room temperatures are high during most of the year. The drugs that can be stored at ambient temperatures are sorely needed.</p>
<p>Another important limitation is the unsatisfactory treatment of PKDL. The current recommendation is treatment with oral MF for 84 days. In addition to being of an unduly prolonged duration, its potential teratogenicity, non-compliance, and significant ocular toxicity make this regimen unsuitable for widespread deployment in the community. There is an urgent need to find a suitable, short, and safe treatment for PKDL in the ISC.</p>
<p>As the number of VL and PKDL patients has gone down significantly, it will be a challenge to cater to these patients, who are sporadically located in various endemic districts. Regional depots should be created at strategic locations easily accessible to the entire region. Availability of rK39 rapid diagnostic test should be ensured in the health facilities in all endemic regions/districts even after reaching the elimination target, for early detection and treatment.</p></section></section><section id="sec011"><h2 class="pmc_sec_title">Conclusions</h2>
<p>KAEP has been a successful endeavor with the achievement of the goal of the elimination of VL in India. Early diagnosis by rK39 rapid test and the availability of an oral drug, MF, were tailor-made for this endeavor, compared to the dependence on invasive and risky parasitological diagnosis, and toxic and ineffective therapy. Later, the introduction of single-dose L-AmB complete treatment further accelerated the pace of success. These tools were the major difference that separated this effort from earlier unsuccessful attempts to control and eliminate this dreaded disease. The new tools also limited the transmission chain to a low level, and the number of patients decreased at a greater pace. The strong political support was of great value, and the Central and State governments worked in tandem. WHO (Geneva and SEARO) also played a stellar role; several external not-for-profit organizations joined hands. Post-elimination, it is a challenge to keep the incidence of VL at or below the elimination goal. Two major threats to sustain the achievement of KAEP are PKDL and HIV-VL co-infection. Both conditions are human reservoirs of the parasite. In these ailments, patients either do not want the treatment, as in PKDL, and in HIV-VL coinfection, patients keep relapsing till the immune status improves with successful antiretroviral treatment. On the other hand, the treatment regimens of PKDL remain unsatisfactory. These two remain a threat for new outbreaks as low levels of community transmission increase the susceptible population with low immunity and thereby increase susceptibility. Active case detection for early recognition of VL and PKDL, and early diagnosis and treatment is of paramount importance. Sustained vector control is another important component. IRS should be continued with the same vigor and zeal as in the pre-elimination era. Strong political commitment with continued availability of the resources, continued vector control, active case detection not only of VL but also PKDL and prompt and complete treatment remain important to sustain the achievements of KAEP.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>The author received no specific funding for this work.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="pntd.0013321.ref001">
<span class="label">1.</span><cite>Leishmaniasis. [cited 2025 Jan 1]. Available from: <a href="https://www.who.int/health-topics/leishmaniasis#tab=tab_1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.who.int/health-topics/leishmaniasis#tab=tab_1</a></cite> [<a href="https://scholar.google.com/scholar_lookup?Leishmaniasis.%20%5Bcited%202025%20Jan%201%5D.%20Available%20from:%20https://www.who.int/health-topics/leishmaniasis#tab=tab_1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref002">
<span class="label">2.</span><cite>Leishmaniasis. [cited 2025 Jan 1]. Available from: <a href="https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/leishmaniasis" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/leishmaniasis</a></cite> [<a href="https://scholar.google.com/scholar_lookup?Leishmaniasis.%20%5Bcited%202025%20Jan%201%5D.%20Available%20from:%20https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/leishmaniasis" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref003">
<span class="label">3.</span><cite>Kushwaha AK, Shukla A, Scorza BM, Chaubey R, Maurya DK, Rai TK, et al. Dogs as reservoirs for <em>Leishmania donovani</em>, Bihar, India, 2018–2022. Emerg Infect Dis. 2024;30(12):2604–13.
</cite> [<a href="https://doi.org/10.3201/eid3012.240649" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11616638/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39592395/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Emerg%20Infect%20Dis&amp;title=Dogs%20as%20reservoirs%20for%20Leishmania%20donovani,%20Bihar,%20India,%202018%E2%80%932022&amp;author=AK%20Kushwaha&amp;author=A%20Shukla&amp;author=BM%20Scorza&amp;author=R%20Chaubey&amp;author=DK%20Maurya&amp;volume=30&amp;issue=12&amp;publication_year=2024&amp;pages=2604-13&amp;pmid=39592395&amp;doi=10.3201/eid3012.240649&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref004">
<span class="label">4.</span><cite>Gill N, Pandey D, Roy N, Dhingra N, Jain S. Kala-azar in India: progress and challenges towards its elimination as a public health problem. WER. 2021;26. Available from: <a href="https://iris.who.int/bitstream/handle/10665/342263/WER9626-267-279-eng-fre.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://iris.who.int/bitstream/handle/10665/342263/WER9626-267-279-eng-fre.pdf</a></cite> [<a href="https://scholar.google.com/scholar_lookup?journal=WER&amp;title=Kala-azar%20in%20India:%20progress%20and%20challenges%20towards%20its%20elimination%20as%20a%20public%20health%20problem&amp;author=N%20Gill&amp;author=D%20Pandey&amp;author=N%20Roy&amp;author=N%20Dhingra&amp;author=S%20Jain&amp;volume=26&amp;publication_year=2021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref005">
<span class="label">5.</span><cite>Sanyal RK. A longitudinal review of kala-azar in Bihar. J Communicable Dis. 1979;(11):149–69. Available from: <a href="https://wellcomecollection.org/works/x3jpkvzu" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://wellcomecollection.org/works/x3jpkvzu</a></cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Communicable%20Dis&amp;title=A%20longitudinal%20review%20of%20kala-azar%20in%20Bihar&amp;author=RK%20Sanyal&amp;issue=11&amp;publication_year=1979&amp;pages=149-69&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref006">
<span class="label">6.</span><cite>Bora D. Epidemiology of visceral leishmaniasis in India. Natl Med J India. 1999;12(2):62–8. 
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/10416321/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Natl%20Med%20J%20India&amp;title=Epidemiology%20of%20visceral%20leishmaniasis%20in%20India&amp;author=D%20Bora&amp;volume=12&amp;issue=2&amp;publication_year=1999&amp;pages=62-8&amp;pmid=10416321&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref007">
<span class="label">7.</span><cite>Singh VP, Ranjan A, Topno RK, Verma RB, Siddique NA, Ravidas VN, et al. Estimation of under-reporting of visceral leishmaniasis cases in Bihar, India. Am J Trop Med Hyg. 2010;82(1):9–11. doi: 10.4269/ajtmh.2010.09-0235

</cite> [<a href="https://doi.org/10.4269/ajtmh.2010.09-0235" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2803501/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20064987/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Trop%20Med%20Hyg&amp;title=Estimation%20of%20under-reporting%20of%20visceral%20leishmaniasis%20cases%20in%20Bihar,%20India&amp;author=VP%20Singh&amp;author=A%20Ranjan&amp;author=RK%20Topno&amp;author=RB%20Verma&amp;author=NA%20Siddique&amp;volume=82&amp;issue=1&amp;publication_year=2010&amp;pages=9-11&amp;pmid=20064987&amp;doi=10.4269/ajtmh.2010.09-0235&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref008">
<span class="label">8.</span><cite>Singh SP, Reddy DCS, Rai M, Sundar S. Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India. Trop Med Int Health. 2006;11(6):899–905. doi: 10.1111/j.1365-3156.2006.01647.x

</cite> [<a href="https://doi.org/10.1111/j.1365-3156.2006.01647.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16772012/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trop%20Med%20Int%20Health&amp;title=Serious%20underreporting%20of%20visceral%20leishmaniasis%20through%20passive%20case%20reporting%20in%20Bihar,%20India&amp;author=SP%20Singh&amp;author=DCS%20Reddy&amp;author=M%20Rai&amp;author=S%20Sundar&amp;volume=11&amp;issue=6&amp;publication_year=2006&amp;pages=899-905&amp;pmid=16772012&amp;doi=10.1111/j.1365-3156.2006.01647.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref009">
<span class="label">9.</span><cite>National Center for Vector Borne Diseases Control (NCVBDC). National Kala-Azar Elimination Programme. [cited 2025 Jan 1]. Available from: <a href="https://ncvbdc.mohfw.gov.in/index1.php?lang=1&amp;level=2&amp;sublinkid=5946&amp;lid=3752" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://ncvbdc.mohfw.gov.in/index1.php?lang=1&amp;level=2&amp;sublinkid=5946&amp;lid=3752</a></cite> [<a href="https://scholar.google.com/scholar_lookup?National%20Center%20for%20Vector%20Borne%20Diseases%20Control%20(NCVBDC).%20National%20Kala-Azar%20Elimination%20Programme.%20%5Bcited%202025%20Jan%201%5D.%20Available%20from:%20https://ncvbdc.mohfw.gov.in/index1.php?lang=1&amp;level=2&amp;sublinkid=5946&amp;lid=3752" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref010">
<span class="label">10.</span><cite>Sundar S, Singh VP, Sharma S, Makharia MK, Murray HW. Response to interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis. J Infect Dis. 1997;176(4):1117–9. doi: 10.1086/516526

</cite> [<a href="https://doi.org/10.1086/516526" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9333181/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Infect%20Dis&amp;title=Response%20to%20interferon-gamma%20plus%20pentavalent%20antimony%20in%20Indian%20visceral%20leishmaniasis&amp;author=S%20Sundar&amp;author=VP%20Singh&amp;author=S%20Sharma&amp;author=MK%20Makharia&amp;author=HW%20Murray&amp;volume=176&amp;issue=4&amp;publication_year=1997&amp;pages=1117-9&amp;pmid=9333181&amp;doi=10.1086/516526&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref011">
<span class="label">11.</span><cite>Sundar S, More DK, Singh MK, Singh VP, Sharma S, Makharia A, et al. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis. 2000;31(4):1104–7. doi: 10.1086/318121

</cite> [<a href="https://doi.org/10.1086/318121" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11049798/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Infect%20Dis&amp;title=Failure%20of%20pentavalent%20antimony%20in%20visceral%20leishmaniasis%20in%20India:%20report%20from%20the%20center%20of%20the%20Indian%20epidemic&amp;author=S%20Sundar&amp;author=DK%20More&amp;author=MK%20Singh&amp;author=VP%20Singh&amp;author=S%20Sharma&amp;volume=31&amp;issue=4&amp;publication_year=2000&amp;pages=1104-7&amp;pmid=11049798&amp;doi=10.1086/318121&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref012">
<span class="label">12.</span><cite>Sundar S, Jha TK, Thakur CP, Engel J, Sindermann H, Fischer C. Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med. 2002;347(22):1739–46.
</cite> [<a href="https://doi.org/10.1056/NEJMoa021556" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12456849/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Oral%20miltefosine%20for%20Indian%20visceral%20leishmaniasis&amp;author=S%20Sundar&amp;author=TK%20Jha&amp;author=CP%20Thakur&amp;author=J%20Engel&amp;author=H%20Sindermann&amp;volume=347&amp;issue=22&amp;publication_year=2002&amp;pages=1739-46&amp;pmid=12456849&amp;doi=10.1056/NEJMoa021556&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref013">
<span class="label">13.</span><cite>Sundar S, Jha TK, Thakur CP, Sinha PK, Bhattacharya SK. Injectable paromomycin for visceral leishmaniasis in India. N Engl J Med. 2007;356(25):2571–81.
</cite> [<a href="https://doi.org/10.1056/NEJMoa066536" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17582067/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Injectable%20paromomycin%20for%20visceral%20leishmaniasis%20in%20India&amp;author=S%20Sundar&amp;author=TK%20Jha&amp;author=CP%20Thakur&amp;author=PK%20Sinha&amp;author=SK%20Bhattacharya&amp;volume=356&amp;issue=25&amp;publication_year=2007&amp;pages=2571-81&amp;pmid=17582067&amp;doi=10.1056/NEJMoa066536&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref014">
<span class="label">14.</span><cite>New therapy for visceral leishmaniasis: India licenses miltefosine, the first oral drug for visceral leishmaniasis [Internet]. [cited 2025 Jan 1]. Available from: <a href="https://www.who.int/publications/i/item/who-wer7725" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.who.int/publications/i/item/who-wer7725</a></cite>
</li>
<li id="pntd.0013321.ref015">
<span class="label">15.</span><cite>Sundar S, Reed SG, Singh VP, Kumar PC, Murray HW. Rapid accurate field diagnosis of Indian visceral leishmaniasis. Lancet. 1998;351(9102):563–5. doi: 10.1016/S0140-6736(97)04350-X

</cite> [<a href="https://doi.org/10.1016/S0140-6736(97)04350-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9492776/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Rapid%20accurate%20field%20diagnosis%20of%20Indian%20visceral%20leishmaniasis&amp;author=S%20Sundar&amp;author=SG%20Reed&amp;author=VP%20Singh&amp;author=PC%20Kumar&amp;author=HW%20Murray&amp;volume=351&amp;issue=9102&amp;publication_year=1998&amp;pages=563-5&amp;pmid=9492776&amp;doi=10.1016/S0140-6736(97)04350-X&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref016">
<span class="label">16.</span><cite>Bhattacharya SK, Dash AP. Elimination of kala-azar from the southeast asia region. Am J Trop Med Hyg. 2017;96(4):802–4. doi: 10.4269/ajtmh.16-0279

</cite> [<a href="https://doi.org/10.4269/ajtmh.16-0279" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5392624/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28115678/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Trop%20Med%20Hyg&amp;title=Elimination%20of%20kala-azar%20from%20the%20southeast%20asia%20region&amp;author=SK%20Bhattacharya&amp;author=AP%20Dash&amp;volume=96&amp;issue=4&amp;publication_year=2017&amp;pages=802-4&amp;pmid=28115678&amp;doi=10.4269/ajtmh.16-0279&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref017">
<span class="label">17.</span><cite>Kala-azar Elimination Programme. The elimination strategy. Available from: <a href="https://ncvbdc.mohfw.gov.in/index1.php?lang=1&amp;level=2&amp;sublinkid=5946&amp;lid=3752" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://ncvbdc.mohfw.gov.in/index1.php?lang=1&amp;level=2&amp;sublinkid=5946&amp;lid=3752</a></cite> [<a href="https://scholar.google.com/scholar_lookup?Kala-azar%20Elimination%20Programme.%20The%20elimination%20strategy.%20Available%20from:%20https://ncvbdc.mohfw.gov.in/index1.php?lang=1&amp;level=2&amp;sublinkid=5946&amp;lid=3752" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref018">
<span class="label">18.</span><cite>Global leishmaniasis surveillance updates 2023: 3 years of the NTD road map. [cited 2025 Jan 1]. Available from: <a href="https://www.who.int/publications/i/item/who-wer-9945-653-669" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.who.int/publications/i/item/who-wer-9945-653-669</a></cite> [<a href="https://scholar.google.com/scholar_lookup?Global%20leishmaniasis%20surveillance%20updates%202023:%203%20years%20of%20the%20NTD%20road%20map.%20%5Bcited%202025%20Jan%201%5D.%20Available%20from:%20https://www.who.int/publications/i/item/who-wer-9945-653-669" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref019">
<span class="label">19.</span><cite>Kala-Azar Situation in India. National Center for Vector Borne Diseases Control (NCVBDC). 2025.  [cited 2025 Jan 1]. Available from: <a href="https://ncvbdc.mohfw.gov.in/index4.php?lang=1&amp;level=0&amp;linkid=467&amp;lid=3750" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://ncvbdc.mohfw.gov.in/index4.php?lang=1&amp;level=0&amp;linkid=467&amp;lid=3750</a></cite> [<a href="https://scholar.google.com/scholar_lookup?Kala-Azar%20Situation%20in%20India.%20National%20Center%20for%20Vector%20Borne%20Diseases%20Control%20(NCVBDC).%202025.%20%5Bcited%202025%20Jan%201%5D.%20Available%20from:%20https://ncvbdc.mohfw.gov.in/index4.php?lang=1&amp;level=0&amp;linkid=467&amp;lid=3750" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref020">
<span class="label">20.</span><cite>Global leishmaniasis surveillance updates 2023: 3 years of the NTD road map. 2023. Available from: <a href="https://iris.who.int/bitstream/handle/10665/379491/WER9945-653-669.pdf?sequence=1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://iris.who.int/bitstream/handle/10665/379491/WER9945-653-669.pdf?sequence=1</a></cite> [<a href="https://scholar.google.com/scholar_lookup?Global%20leishmaniasis%20surveillance%20updates%202023:%203%20years%20of%20the%20NTD%20road%20map.%202023.%20Available%20from:%20https://iris.who.int/bitstream/handle/10665/379491/WER9945-653-669.pdf?sequence=1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref021">
<span class="label">21.</span><cite>Singh OP, Tiwary P, Kushwaha AK, Singh SK, Singh DK, Lawyer P, et al. Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study. Lancet Microbe. 2021;2(1):e23–31. doi: 10.1016/S2666-5247(20)30166-X

</cite> [<a href="https://doi.org/10.1016/S2666-5247(20)30166-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7869864/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33615281/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Microbe&amp;title=Xenodiagnosis%20to%20evaluate%20the%20infectiousness%20of%20humans%20to%20sandflies%20in%20an%20area%20endemic%20for%20visceral%20leishmaniasis%20in%20Bihar,%20India:%20a%20transmission-dynamics%20study&amp;author=OP%20Singh&amp;author=P%20Tiwary&amp;author=AK%20Kushwaha&amp;author=SK%20Singh&amp;author=DK%20Singh&amp;volume=2&amp;issue=1&amp;publication_year=2021&amp;pmid=33615281&amp;doi=10.1016/S2666-5247(20)30166-X&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref022">
<span class="label">22.</span><cite>Mondal D, Bern C, Ghosh D, Rashid M, Molina R, Chowdhury R, et al. Quantifying the infectiousness of post-kala-azar dermal leishmaniasis toward sand flies. Clin Infect Dis. 2019;69(2):251–8.
</cite> [<a href="https://doi.org/10.1093/cid/ciy891" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6603265/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30357373/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Infect%20Dis&amp;title=Quantifying%20the%20infectiousness%20of%20post-kala-azar%20dermal%20leishmaniasis%20toward%20sand%20flies&amp;author=D%20Mondal&amp;author=C%20Bern&amp;author=D%20Ghosh&amp;author=M%20Rashid&amp;author=R%20Molina&amp;volume=69&amp;issue=2&amp;publication_year=2019&amp;pages=251-8&amp;pmid=30357373&amp;doi=10.1093/cid/ciy891&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref023">
<span class="label">23.</span><cite>Sundar S, Chakravarty J, Agarwal D, Rai M, Murray HW. Single-dose liposomal amphotericin B for visceral leishmaniasis in India. N Engl J Med. 2010;362(6):504–12.
</cite> [<a href="https://doi.org/10.1056/NEJMoa0903627" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20147716/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Single-dose%20liposomal%20amphotericin%20B%20for%20visceral%20leishmaniasis%20in%20India&amp;author=S%20Sundar&amp;author=J%20Chakravarty&amp;author=D%20Agarwal&amp;author=M%20Rai&amp;author=HW%20Murray&amp;volume=362&amp;issue=6&amp;publication_year=2010&amp;pages=504-12&amp;pmid=20147716&amp;doi=10.1056/NEJMoa0903627&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref024">
<span class="label">24.</span><cite>Gedda MR, Singh B, Kumar D, Singh AK, Madhukar P, Upadhyay S. Post kala-azar dermal leishmaniasis: a threat to elimination program. PLoS Negl Trop Dis. 2020;14(7):e0008221. doi: 10.1371/journal.pntd.0008221</cite> [<a href="https://doi.org/10.1371/journal.pntd.0008221" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7332242/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32614818/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Negl%20Trop%20Dis&amp;title=Post%20kala-azar%20dermal%20leishmaniasis:%20a%20threat%20to%20elimination%20program&amp;author=MR%20Gedda&amp;author=B%20Singh&amp;author=D%20Kumar&amp;author=AK%20Singh&amp;author=P%20Madhukar&amp;volume=14&amp;issue=7&amp;publication_year=2020&amp;pmid=32614818&amp;doi=10.1371/journal.pntd.0008221&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref025">
<span class="label">25.</span><cite>Thakur CP, Kumar K. Efficacy of prolonged therapy with stibogluconate in post kala-azar dermal leishmaniasis. Indian J Med Res. 1990;91:144–8.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/2160914/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Indian%20J%20Med%20Res&amp;title=Efficacy%20of%20prolonged%20therapy%20with%20stibogluconate%20in%20post%20kala-azar%20dermal%20leishmaniasis&amp;author=CP%20Thakur&amp;author=K%20Kumar&amp;volume=91&amp;publication_year=1990&amp;pages=144-8&amp;pmid=2160914&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref026">
<span class="label">26.</span><cite>Thakur CP, Narain S, Kumar N, Hassan SM, Jha DK, Kumar A. Amphotericin B is superior to sodium antimony gluconate in the treatment of Indian post-kala-azar dermal leishmaniasis. Ann Trop Med Parasitol. 1997;91(6):611–6. doi: 10.1080/00034989760707

</cite> [<a href="https://doi.org/10.1080/00034989760707" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9425363/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Trop%20Med%20Parasitol&amp;title=Amphotericin%20B%20is%20superior%20to%20sodium%20antimony%20gluconate%20in%20the%20treatment%20of%20Indian%20post-kala-azar%20dermal%20leishmaniasis&amp;author=CP%20Thakur&amp;author=S%20Narain&amp;author=N%20Kumar&amp;author=SM%20Hassan&amp;author=DK%20Jha&amp;volume=91&amp;issue=6&amp;publication_year=1997&amp;pages=611-6&amp;pmid=9425363&amp;doi=10.1080/00034989760707&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref027">
<span class="label">27.</span><cite>Sundar S, Sinha P, Jha TK, Chakravarty J, Rai M, Kumar N, et al. Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial. Trop Med Int Health. 2013;18(1):96–100. doi: 10.1111/tmi.12015

</cite> [<a href="https://doi.org/10.1111/tmi.12015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23136856/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trop%20Med%20Int%20Health&amp;title=Oral%20miltefosine%20for%20Indian%20post-kala-azar%20dermal%20leishmaniasis:%20a%20randomised%20trial&amp;author=S%20Sundar&amp;author=P%20Sinha&amp;author=TK%20Jha&amp;author=J%20Chakravarty&amp;author=M%20Rai&amp;volume=18&amp;issue=1&amp;publication_year=2013&amp;pages=96-100&amp;pmid=23136856&amp;doi=10.1111/tmi.12015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref028">
<span class="label">28.</span><cite>Addy M, Nandy A. Ten years of kala-azar in west Bengal, Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas?
Bull World Health Organ. 1992;70(3):341–6. 
</cite> [<a href="/articles/PMC2393278/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1638662/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bull%20World%20Health%20Organ&amp;title=Ten%20years%20of%20kala-azar%20in%20west%20Bengal,%20Part%20I.%20Did%20post-kala-azar%20dermal%20leishmaniasis%20initiate%20the%20outbreak%20in%2024-Parganas?&amp;author=M%20Addy&amp;author=A%20Nandy&amp;volume=70&amp;issue=3&amp;publication_year=1992&amp;pages=341-6&amp;pmid=1638662&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref029">
<span class="label">29.</span><cite>Swaminath CS, Shortt HE, Anderson LAP. Transmission of Indian kala-azar to man by the bites of Phlebotomus argentipes, ann and brun. 1942. Indian J Med Res. 2006;123(3):473–7. 
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/16789343/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Indian%20J%20Med%20Res&amp;title=Transmission%20of%20Indian%20kala-azar%20to%20man%20by%20the%20bites%20of%20Phlebotomus%20argentipes,%20ann%20and%20brun.%201942&amp;author=CS%20Swaminath&amp;author=HE%20Shortt&amp;author=LAP%20Anderson&amp;volume=123&amp;issue=3&amp;publication_year=2006&amp;pages=473-7&amp;pmid=16789343&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref030">
<span class="label">30.</span><cite>Thakur CP, Kumar K, Sinha PK, Mishra BN, Pandey AK. Treatment of post-kala-azar dermal leishmaniasis with sodium stibogluconate. Br Med J (Clin Res Ed). 1987;295(6603):886–7.</cite> [<a href="https://doi.org/10.1136/bmj.295.6603.886-a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1247932/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2823955/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20Med%20J%20(Clin%20Res%20Ed)&amp;title=Treatment%20of%20post-kala-azar%20dermal%20leishmaniasis%20with%20sodium%20stibogluconate&amp;author=CP%20Thakur&amp;author=K%20Kumar&amp;author=PK%20Sinha&amp;author=BN%20Mishra&amp;author=AK%20Pandey&amp;volume=295&amp;issue=6603&amp;publication_year=1987&amp;pages=886-7&amp;pmid=2823955&amp;doi=10.1136/bmj.295.6603.886-a&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref031">
<span class="label">31.</span><cite>World Health Organization. Control of the leishmaniasis—WHO Technical Report Series No. 949. 2010.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/21485694/" class="usa-link">PubMed</a>]</li>
<li id="pntd.0013321.ref032">
<span class="label">32.</span><cite>Sundar S, Singh J, Dinkar A, Agrawal N. Safety and effectiveness of miltefosine in post-kala-azar dermal leishmaniasis: an observational study. Open Forum Infect Dis. 2023;10(5):ofad231. doi: 10.1093/ofid/ofad231

</cite> [<a href="https://doi.org/10.1093/ofid/ofad231" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10205550/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37234513/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Open%20Forum%20Infect%20Dis&amp;title=Safety%20and%20effectiveness%20of%20miltefosine%20in%20post-kala-azar%20dermal%20leishmaniasis:%20an%20observational%20study&amp;author=S%20Sundar&amp;author=J%20Singh&amp;author=A%20Dinkar&amp;author=N%20Agrawal&amp;volume=10&amp;issue=5&amp;publication_year=2023&amp;pmid=37234513&amp;doi=10.1093/ofid/ofad231&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref033">
<span class="label">33.</span><cite>Sundar S, Pandey K, Mondal D, Madhukar M, Kamal Topno R, Kumar A, et al. A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh. PLoS Negl Trop Dis. 2024;18(6):e0012242. doi: 10.1371/journal.pntd.0012242

</cite> [<a href="https://doi.org/10.1371/journal.pntd.0012242" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11189210/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38900786/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Negl%20Trop%20Dis&amp;title=A%20phase%20II,%20non-comparative%20randomised%20trial%20of%20two%20treatments%20involving%20liposomal%20amphotericin%20B%20and%20miltefosine%20for%20post-kala-azar%20dermal%20leishmaniasis%20in%20India%20and%20Bangladesh&amp;author=S%20Sundar&amp;author=K%20Pandey&amp;author=D%20Mondal&amp;author=M%20Madhukar&amp;author=R%20Kamal%20Topno&amp;volume=18&amp;issue=6&amp;publication_year=2024&amp;pmid=38900786&amp;doi=10.1371/journal.pntd.0012242&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref034">
<span class="label">34.</span><cite>Mathur P, Samantaray JC, Vajpayee M, Samanta P. Visceral leishmaniasis/human immunodeficiency virus co-infection in India: the focus of two epidemics. J Med Microbiol. 2006;55(Pt 7):919–22.
</cite> [<a href="https://doi.org/10.1099/jmm.0.46574-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16772420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Microbiol&amp;title=Visceral%20leishmaniasis/human%20immunodeficiency%20virus%20co-infection%20in%20India:%20the%20focus%20of%20two%20epidemics&amp;author=P%20Mathur&amp;author=JC%20Samantaray&amp;author=M%20Vajpayee&amp;author=P%20Samanta&amp;volume=55&amp;publication_year=2006&amp;pages=919-22&amp;pmid=16772420&amp;doi=10.1099/jmm.0.46574-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref035">
<span class="label">35.</span><cite>Burza S, Mahajan R, Sanz MG, Sunyoto T, Kumar R, Mitra G, et al. HIV and visceral leishmaniasis coinfection in Bihar, India: an underrecognized and underdiagnosed threat against elimination. Clin Infect Dis. 2014;59(4):552–5. doi: 10.1093/cid/ciu333

</cite> [<a href="https://doi.org/10.1093/cid/ciu333" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24814660/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Infect%20Dis&amp;title=HIV%20and%20visceral%20leishmaniasis%20coinfection%20in%20Bihar,%20India:%20an%20underrecognized%20and%20underdiagnosed%20threat%20against%20elimination&amp;author=S%20Burza&amp;author=R%20Mahajan&amp;author=MG%20Sanz&amp;author=T%20Sunyoto&amp;author=R%20Kumar&amp;volume=59&amp;issue=4&amp;publication_year=2014&amp;pages=552-5&amp;pmid=24814660&amp;doi=10.1093/cid/ciu333&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref036">
<span class="label">36.</span><cite>Singh S. Changing trends in the epidemiology, clinical presentation, and diagnosis of Leishmania–HIV co-infection in India. Int J Infectious Dis. 2014. 
Dec
1;29:103–12.
</cite> [<a href="https://doi.org/10.1016/j.ijid.2014.07.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25449244/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Infectious%20Dis&amp;title=Changing%20trends%20in%20the%20epidemiology,%20clinical%20presentation,%20and%20diagnosis%20of%20Leishmania%E2%80%93HIV%20co-infection%20in%20India&amp;author=S%20Singh&amp;volume=29&amp;publication_year=2014&amp;pages=103-12&amp;pmid=25449244&amp;doi=10.1016/j.ijid.2014.07.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref037">
<span class="label">37.</span><cite>Visceral leishmaniasis and HIV coinfection: WHO publishes new guideline with region-specific treatment recommendations. [cited 2023 Oct 1]. Available from: <a href="https://www.who.int/news/item/08-06-2022-visceral-leishmaniasis-and-HIV-coinfection-WHO-publishes-new-guideline-with-region-specific-treatment-recommendations" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.who.int/news/item/08-06-2022-visceral-leishmaniasis-and-HIV-coinfection-WHO-publishes-new-guideline-with-region-specific-treatment-recommendations</a></cite> [<a href="https://scholar.google.com/scholar_lookup?Visceral%20leishmaniasis%20and%20HIV%20coinfection:%20WHO%20publishes%20new%20guideline%20with%20region-specific%20treatment%20recommendations.%20%5Bcited%202023%20Oct%201%5D.%20Available%20from:%20https://www.who.int/news/item/08-06-2022-visceral-leishmaniasis-and-HIV-coinfection-WHO-publishes-new-guideline-with-region-specific-treatment-recommendations" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref038">
<span class="label">38.</span><cite>Singh OP, Chaubey R, Kushwaha AK, Fay MP, Sacks D, Sundar S. Visceral leishmaniasis-human immunodeficiency virus-coinfected patients are highly infectious to sandflies in an endemic area in India. J Infect Dis. 2024;229(6):1909–12.
</cite> [<a href="https://doi.org/10.1093/infdis/jiae156" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11175680/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38713583/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Infect%20Dis&amp;title=Visceral%20leishmaniasis-human%20immunodeficiency%20virus-coinfected%20patients%20are%20highly%20infectious%20to%20sandflies%20in%20an%20endemic%20area%20in%20India&amp;author=OP%20Singh&amp;author=R%20Chaubey&amp;author=AK%20Kushwaha&amp;author=MP%20Fay&amp;author=D%20Sacks&amp;volume=229&amp;issue=6&amp;publication_year=2024&amp;pages=1909-12&amp;pmid=38713583&amp;doi=10.1093/infdis/jiae156&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref039">
<span class="label">39.</span><cite>WHO guidelines for the treatment of visceral leishmaniasis in HIV co-infected patients in East Africa and South-East Asia. World Health Organization; 2023. <a href="https://www.who.int/publications/i/item/9789240048294" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.who.int/publications/i/item/9789240048294</a></cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/35763584/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?title=WHO%20guidelines%20for%20the%20treatment%20of%20visceral%20leishmaniasis%20in%20HIV%20co-infected%20patients%20in%20East%20Africa%20and%20South-East%20Asia&amp;publication_year=2023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref040">
<span class="label">40.</span><cite>Dhiman RC, Yadav RS. Insecticide resistance in phlebotomine sandflies in Southeast Asia with emphasis on the Indian subcontinent. Infect Dis Poverty. 2016;5(1):106. doi: 10.1186/s40249-016-0200-3

</cite> [<a href="https://doi.org/10.1186/s40249-016-0200-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5098277/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27817749/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Infect%20Dis%20Poverty&amp;title=Insecticide%20resistance%20in%20phlebotomine%20sandflies%20in%20Southeast%20Asia%20with%20emphasis%20on%20the%20Indian%20subcontinent&amp;author=RC%20Dhiman&amp;author=RS%20Yadav&amp;volume=5&amp;issue=1&amp;publication_year=2016&amp;pages=106&amp;pmid=27817749&amp;doi=10.1186/s40249-016-0200-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref041">
<span class="label">41.</span><cite>Chaubey R, Shukla A, Kushwaha AK, Tiwary P, Kumar Singh S, Hennings S, et al. Assessing insecticide susceptibility, diagnostic dose and time for the sand fly Phlebotomus argentipes, the vector of visceral leishmaniasis in India, using the CDC bottle bioassay. PLoS Negl Trop Dis. 2023;17(5):e0011276. doi: 10.1371/journal.pntd.0011276

</cite> [<a href="https://doi.org/10.1371/journal.pntd.0011276" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10202287/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37163529/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Negl%20Trop%20Dis&amp;title=Assessing%20insecticide%20susceptibility,%20diagnostic%20dose%20and%20time%20for%20the%20sand%20fly%20Phlebotomus%20argentipes,%20the%20vector%20of%20visceral%20leishmaniasis%20in%20India,%20using%20the%20CDC%20bottle%20bioassay&amp;author=R%20Chaubey&amp;author=A%20Shukla&amp;author=AK%20Kushwaha&amp;author=P%20Tiwary&amp;author=S%20Kumar%20Singh&amp;volume=17&amp;issue=5&amp;publication_year=2023&amp;pmid=37163529&amp;doi=10.1371/journal.pntd.0011276&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref042">
<span class="label">42.</span><cite>Kumar V, Kesari S, Kumar AJ, Dinesh DS, Ranjan A, Prasad M, et al. Vector density and the control of kala-azar in Bihar, India. Mem Inst Oswaldo Cruz. 2009;104(7):1019–22. doi: 10.1590/s0074-02762009000700014

</cite> [<a href="https://doi.org/10.1590/s0074-02762009000700014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20027471/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mem%20Inst%20Oswaldo%20Cruz&amp;title=Vector%20density%20and%20the%20control%20of%20kala-azar%20in%20Bihar,%20India&amp;author=V%20Kumar&amp;author=S%20Kesari&amp;author=AJ%20Kumar&amp;author=DS%20Dinesh&amp;author=A%20Ranjan&amp;volume=104&amp;issue=7&amp;publication_year=2009&amp;pages=1019-22&amp;pmid=20027471&amp;doi=10.1590/s0074-02762009000700014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pntd.0013321.ref043">
<span class="label">43.</span><cite>Kaul SM, Das RK, Shiv Raj SR, Saxena NBL, Narasimham MVVL. Entomological monitoring of kala-azar control in Bihar state, India: observations in Vaishali and Patna districts. J Commun Dis. 1993;25:101–6.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Commun%20Dis&amp;title=Entomological%20monitoring%20of%20kala-azar%20control%20in%20Bihar%20state,%20India:%20observations%20in%20Vaishali%20and%20Patna%20districts&amp;author=SM%20Kaul&amp;author=RK%20Das&amp;author=SR%20Shiv%20Raj&amp;author=NBL%20Saxena&amp;author=MVVL%20Narasimham&amp;volume=25&amp;publication_year=1993&amp;pages=101-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from PLOS Neglected Tropical Diseases are provided here courtesy of <strong>PLOS</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1371/journal.pntd.0013321"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/pntd.0013321.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (607.1 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12364345/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12364345/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12364345%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364345/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12364345/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12364345/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40828749/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12364345/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40828749/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12364345/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12364345/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="LoI7Wziec2NdP2TWobbDLV7cs9aHPtjNKWm8Xai5Rx69Rd0c1GRHXmhjtbg4Tc2k">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
